• Explore /
  • Poster
  • / Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers.

Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers.

Abstract Poster

Authors

null

Rudolph M. Navari

Indiana University School of Medicine South Bend, South Bend, IN

Rudolph M. Navari, Karin Jordan, Bernardo Leon Rapoport, Ian D. Schnadig, Martin Chasen, Sujata Arora, Daniel Powers, Lee Steven Schwartzberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Palliative and Supportive Care in Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Biologic Basis of Symptoms and Treatment Toxicities,Psycho-oncology,End-of-Life Care,Survivorship,Management/Prevention of Symptoms and Treatment Toxicities,Psychosocial and Spiritual Care,Communication in Advanced Cancer

Sub Track

Treatment toxicity

Clinical Trial Registration Number

NCT01500226, NCT01499849, NCT01500213

Citation

J Clin Oncol 34, 2016 (suppl 26S; abstr 222)

DOI

10.1200/jco.2016.34.26_suppl.222

Abstract #

222

Poster Bd #

H12

Abstract Disclosures

Similar Posters

First Author: Laszlo Urban

First Author: Ian D. Schnadig

Poster

2016 Palliative and Supportive Care in Oncology Symposium

Rolapitant for control of chemotherapy-induced nausea and vomiting (CINV) in patients with gynecologic cancer.

Rolapitant for control of chemotherapy-induced nausea and vomiting (CINV) in patients with gynecologic cancer.

First Author: Bernardo Leon Rapoport

First Author: Bernardo Leon Rapoport